Pfizer Secures $1.5B Deal for Obesity Drug
Pfizer secures up to $1.5 billion in development funding from Blackstone Life…
Wegovy Pill Sales Drive Stronger 2026 Outlook
Novo Nordisk raises its 2026 financial outlook for the third time as…
Clinical Study Explores Precision Nutrition to Support Patients on GLP-1 Therapy
M42’s IROS and 10XREVIV launch a clinical study to assess how precision…
Bahrain Approves Oral Wegovy for Obesity Treatment
Bahrain approves oral Wegovy (semaglutide) for obesity treatment, becoming the second GCC…
WHO Advises Against Obesity Medicines for Children Under 10
WHO advises against obesity medicines and GLP-1 weight-loss injections for children under…
World Heart Day: Why Heart Health Conversations Must Include Obesity
World Heart Day highlights the strong link between obesity and cardiovascular disease,…
Digital Care Model Expands Doctor-Led GLP-1 Weight Management in UAE
Valeo Health reports a 60% rise in UAE consultations as its doctor-led…
EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
UAE Becomes a Global Testing Ground for the Weight Loss Pill Everyone’s Talking About
The UAE has become the second country globally to approve oral Wegovy…
UAE becomes second country globally to approve Wegovy pill for weight loss
The UAE has become the second country worldwide to approve the oral…
